{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:04:26Z","timestamp":1774364666892,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jpba.2012.01.037","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T10:45:17Z","timestamp":1328611517000},"page":"151-159","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Applicability of total reflection X-ray fluorescence (TXRF) as a screening platform for pharmaceutical inorganic impurity analysis"],"prefix":"10.1016","volume":"63","author":[{"given":"Bradley J.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Semin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith R.","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2012.01.037_bib0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11095-010-0080-3","article-title":"Metal impurities in food and drugs","volume":"27","author":"Abernethy","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2012.01.037_bib0010","unstructured":"International Conference on Harmonization, Q3 quality guidelines, 2006, www.ich.org."},{"key":"10.1016\/j.jpba.2012.01.037_bib0015","unstructured":"European Medicines Agency, Doc. Ref. EMEA\/CHMP\/SWP\/4446\/2000, London, 21 February 2008."},{"key":"10.1016\/j.jpba.2012.01.037_bib0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/adsc.200404071","article-title":"The art of meeting palladium specifications in active pharmaceutical ingredients produced by Pd-catalyzed reactions","volume":"346","author":"Garrett","year":"2004","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/adsc.200900765","article-title":"Recyclable heterogeneous palladium catalysts in pure water:sustainable developments in Suzuki, Heck, Sonogashira and Tsuji\u2013Trost reactions","volume":"352","author":"Lamblin","year":"2010","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1039\/B608235C","article-title":"Multi-component syntheses of heterocycles by transition-metal catalysis","volume":"36","author":"D'Souza","year":"2007","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jpba.2012.01.037_bib0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1021\/ac8021373","article-title":"Method for the determination of Pd-catalyst residues in active pharmaceutical ingredients by means of high-energy polarized-beam energy dispersive X-ray fluorescence","volume":"81","author":"Margu\u00ed","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2012.01.037_bib0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpba.2010.11.030","article-title":"The use of atomic spectroscopy in the pharmaceutical industry for the determination of trace elements in pharmaceuticals","volume":"55","author":"Lewen","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/a804443k","article-title":"The development of analytical methodology for simultaneous trace elemental analysis of blood plasma samples using total reflection X-ray fluorescence spectrometry","volume":"13","author":"Savage","year":"1998","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.jpba.2012.01.037_bib0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jpba.2010.02.030","article-title":"Use of total reflection X-ray fluorescence (TXRF) for the evaluation of heavy metal poisoning due to the improper use of a traditional ayurvedic drug","volume":"52","author":"Borgese","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002160050633","article-title":"Applications of adsorptive stripping voltammetry for the trace analysis of metals, pharmaceuticals and biomolecules","volume":"360","author":"Abu Zuhri1","year":"1998","journal-title":"Fresenius J. Anal. Chem."},{"key":"10.1016\/j.jpba.2012.01.037_bib0060","unstructured":"Pharmacopoeia of the United States of America, Procedure 121, Time-limit test for heavy metals, 8th revision, Lippincott, Philadelphia, PA, 1905."},{"key":"10.1016\/j.jpba.2012.01.037_bib0065","unstructured":"The United States Pharmacopoeia\/The National Formulary, USP 32\/NF 29, The United States Pharmacopoeia Convention, Rockville, MD, 2011, Chapter 231, Heavy Elements, pp. 135\u2013136."},{"key":"10.1016\/j.jpba.2012.01.037_bib0070","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/ac060712t","article-title":"Inductively coupled plasma mass spectrometry","volume":"78","author":"Beauchemin","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2012.01.037_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9673(02)01239-6","article-title":"Elemental speciation by chromatographic separation with inductively coupled plasma mass spectrometry detection","volume":"974","author":"Ponce de Leon","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2012.01.037_bib0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0731-7085(00)00361-7","article-title":"A multi-element ICP-MS survey method as an alternative to the heavy metals limit test for pharmaceutical materials","volume":"23","author":"Wang","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpba.2005.11.014","article-title":"The application of inductively coupled plasma mass spectrometry in pharmaceutical and biomedical analysis","volume":"40","author":"Huang","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpba.2004.02.023","article-title":"A rapid ICP-MS screen for heavy metals in pharmaceutical compounds","volume":"35","author":"Lewen","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2006.07.004","article-title":"An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals","volume":"43","author":"Rao","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpba.2010.01.008","article-title":"High-efficiency sample preparation with dimethylformamide for multi-element determination in pharmaceutical materials by ICP-AES","volume":"52","author":"Tu","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1063\/1.1685282","article-title":"Optical flats for use in X-ray spectrochemical microanalysis","volume":"42","author":"Yoneda","year":"1971","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.jpba.2012.01.037_bib0110","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0584-8547(03)00193-9","article-title":"Quo Vadis total reflection X-ray fluorescence?","volume":"58","author":"Pahlke","year":"2003","journal-title":"Spectrochim. Acta Part B"},{"key":"10.1016\/j.jpba.2012.01.037_bib0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0584-8547(91)80180-B","article-title":"Historical development and principles of total reflection X-ray fluorescence analysis (TXRF)","volume":"46B","author":"Aiginger","year":"1991","journal-title":"Spectrochim. Acta"},{"key":"10.1016\/j.jpba.2012.01.037_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0584-8547(96)01624-2","article-title":"Trace element determination in drugs by total-reflection X-ray fluorescence spectrometry","volume":"52","author":"Wagner","year":"1997","journal-title":"Spectrochim. Acta Part B"},{"key":"10.1016\/j.jpba.2012.01.037_bib0125","first-page":"969","article-title":"Application of total reflection X-ray fluorescence spectrometry to drug analysis","volume":"vol. 35B","author":"Nomura","year":"1992"},{"key":"10.1016\/j.jpba.2012.01.037_bib0130","first-page":"865","article-title":"Application of total reflection X-ray fluorescence (TXRF) to trace element determination in pharmaceutical substances","volume":"51","author":"Wagner","year":"1996","journal-title":"Pharmazie"},{"key":"10.1016\/j.jpba.2012.01.037_bib0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpba.2009.08.012","article-title":"High-throughput metal screening in pharmaceutical samples by ICP-MS with automated flow injection using a modified HPLC configuration","volume":"51","author":"Tu","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.01.037_bib0140","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/jm101356p","article-title":"Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry","volume":"54","author":"Ishikawa","year":"2011","journal-title":"J. Med. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851200057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851200057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T12:54:17Z","timestamp":1543236857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851200057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"alternative-id":["S073170851200057X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2012.01.037","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}